Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial
This poster was presented by Dr Liliana Nicolosi MD et al from the Hospital Español de Buenos Aires, División Cardiología y Unidad Coronaria – Buenos
This poster was presented by Dr Liliana Nicolosi MD et al from the Hospital Español de Buenos Aires, División Cardiología y Unidad Coronaria – Buenos
This poster was presented by Dr Kamal Awad MD from the Zagazig University – Zagazig – Egypt on Friday 27th August at the ESC Congress
The ESC will be four new guidelines at ESC Congress 2021, to help shape clinical practice and improve patient care. The first of these guidelines,
Dr Peter Kolkhof from the, R&D, division of a pharmaceutical firm from Wuppertal Germany presented this paper on Friday 27th August at the ESC Congress
The effects of pharmacological lowering of blood pressure (BP) on cardiovascular (CV) outcomes in older patients, particularly when BP is not substantially elevated, is uncertain.
The European Society of Cardiology Congress 2021 kicked off as a virtual event today Friday 27th August 2021. Speaking on this eclectic 4- day Congress
In a session presented by Dr Felix Mahfoud MD Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA at the European
The Late Breaking Science Session at the European Society of Cardiology (ESC) Congress 2020 – The Digital Experience on Monday 31st August 2020, began with